Gemelli Biotech Completes $19 Million Series A Financing

LOS ANGELES & RALEIGH, N.C.--(BUSINESS WIRE)--Gemelli Biotech Corp. (“Gemelli”), a company focused on improving health by providing precision diagnostics for gastrointestinal (GI) diseases, today announced the completion of a $19 million Series A financing. Blue Ox Healthcare Partners (“Blue Ox”), a private equity firm providing growth capital to companies targeting...

Click to view original post